MedTrace Logo

Evaluation of the Medical Psychiatry Alliance Senior's Outpatient Collaborative Care Project

NCT03617614 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2021-03-22

No results posted yet for this study

Summary

This study evaluates the effectiveness of a collaborative care model designed to treat frail seniors with both a mental (anxiety and/or depression) and a physical health condition impacting function with a comparison group that receives a psychiatric mood consult and a letter of recommendation but who are mainly cared for by their PCP.

Conditions

Interventions

BEHAVIORAL

Collaborative Care Model

Trained care managers (CM) work collaboratively with patients, caregivers, and primary care providers to provide education, care navigation and behavioral activation. The latter includes a stepped psychotherapy intervention called ENGAGE, that focuses on "reward exposure" engagement in meaningful, rewarding activities for patients. Patients (home) visits are delivered over a period of 6 to 16 weeks. Progress is assessed with standardized measures for depression (PHQ-9), anxiety (GAD-7) and functioning (WHO-DAS). Furthermore, patients are presented by the CM at Systematic Case Review meetings where an integrated team of medical, psychiatric and allied health professionals work collaboratively to review the patient's goals and treatment to formulate a care plan and recommendations.

BEHAVIORAL

Mood Consultation

A meeting with a psychiatrist to do assessment, provide education and make recommendations regarding the care of the patient for the Primary Care Provider.

Sponsors & Collaborators

  • Centre for Addiction and Mental Health

    collaborator OTHER

  • Medical Psychiatry Alliance

    collaborator OTHER

  • Trillium Health Centre

    lead OTHER

Principal Investigators

  • Judith Versloot, PhD · Trillium Health Partners

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2020-01-01
Completion
2020-06-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03617614 on ClinicalTrials.gov